Deciding the duration of blood thinners following acute venous thromboembolism (VTE) by assessing residual venous thrombosis by ultrasound scan

Optimizing duration of anticoagulation following acute venous thromboembolism (VTE) by assessing residual venous thrombosis by ultrasound – a multicenter randomized controlled trial

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/06/053767

Enrollment

440

Registered

2023-06-12

Start date

Unknown

Completion date

Unknown

Last updated

2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I829- Embolism and thrombosis of unspecified vein

Interventions

Intervention1: Multicenter Randomized controlled trial: Consecutive adult patients with symptomatic DVT with or without associated Pulmonary embolism fulfilling inclusion criteria will be eligible to

Eligibility

Inclusion criteria

Inclusion criteria: Adults >18 years diagnosed with acute lower limb DVT with or without associated pulmonary embolism

Exclusion criteria

Exclusion criteria: 1.Previous VTE 2.Any indication for lifelong anticoagulation 3.Contraindications for anticoagulation 4.Active malignancy 5.Pregnancy

Design outcomes

Primary

Measure	Time frame
1.Recurrent VTE 2.Major bleedingTimepoint: 1.30 months from randomization. 2.30 months from randomization.	—

Secondary

Measure	Time frame
Sensitivity and specificity of PoCUS compared to formal venous scanning for detection of residual venous thrombosisTimepoint: 30 Months	—

Countries

India

Contacts

Public ContactDr Aneesh Basheer

Dr Moopens Medical College, Wayanad

basheeraneesh@gmail.com9677154338

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026